Burning Rock Biotech (BNR) Gross Profit (2019 - 2026)

Burning Rock Biotech's Gross Profit history runs 8 years deep, the most recent figure standing at $11.3 million for Q1 2026.

• In Q1 2026, Gross Profit fell 15.74% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $54.4 million (up 4.79% YoY), while the FY2025 annual figure was $57.6 million, up 16.05% from the prior year.
• Gross Profit for Q1 2026 stood at $11.3 million, down from $14.1 million in the prior quarter.
• The five-year high for Gross Profit was $15.3 million in Q3 2022, with the low at $11.0 million in Q4 2023.
• The 5-year median for Gross Profit is $13.4 million (2025), against an average of $13.2 million.
• The sharpest annual moves came in 2022 and 2023: Gross Profit grew 17.64% in 2022, then dropped 25.06% in 2023.
• Burning Rock Biotech's Gross Profit stood at $14.7 million in 2022, then decreased by 25.06% to $11.0 million in 2023, then advanced by 11.35% to $12.3 million in 2024, then climbed by 15.05% to $14.1 million in 2025, then slipped by 19.76% to $11.3 million in 2026.
• Business Quant data shows BNR's Gross Profit at $11.3 million in Q1 2026, $14.1 million in Q4 2025, and $13.9 million in Q3 2025.